ACE2 and infection: Our results indicate that intranasal delivery of SARS CoV-2 to K18-ACE2 mice results in severe disease characterized by high viral loads at early time points that were associated with elevated plasmatic D-dimer concentrations suggestive of coagulation events occurring at early times (days 1 and 2) after infection.